Clinical Trial: Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Phase I/II Study of An Ex Vivo Immunotherapy for Treatment of Idiopathic Aplastic Anemia

Brief Summary: Our hypothesis is that ex vivo activated immune cells would produce multiple known and unknown potent hematopoietic cytokines, working in concert, these cytokines help stem cell growth and differentiation. Additionally, these cells travel and home to bone marrow as well as spleen and liver involved in hematopoietic activities, where direct cell-cell contact may be beneficial.